These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1781371)

  • 21. Abnormalities in S-adenosylhomocysteine hydrolysis, ATP catabolism, and lymphoid differentiation in adenosine deaminase deficiency.
    Hershfield MS; Kurtzberg J; Aiyar VN; Suh EJ; Schiff R
    Ann N Y Acad Sci; 1985; 451():78-86. PubMed ID: 3865575
    [No Abstract]   [Full Text] [Related]  

  • 22. A new mechanism of toxicity of 2-chlorodeoxyadenosine (2CdA).
    Fabianowska-Majewska K; Wasiak TJ; Warzocha K; Marlewski M; Fairbanks L; Smoleński RT; Duley J; Simmonds A
    Adv Exp Med Biol; 1994; 370():125-8. PubMed ID: 7660873
    [No Abstract]   [Full Text] [Related]  

  • 23. Genetics of human S-adenosylhomocysteine hydrolase. A new polymorphism in man.
    Bissbort S; Bender K; Wienker TF; Grzeschik KH
    Hum Genet; 1983; 65(1):68-71. PubMed ID: 6580258
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene frequencies of S-adenosylhomocysteine hydrolase (SAHH) in a Japanese population.
    Akiyama K; Nakamura S; Abe K
    Hum Genet; 1984; 68(2):191-2. PubMed ID: 6500572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenosine deaminase isoenzymes and HIV/HTLV-1 infections.
    Yokoyama MM; Tsuboi I
    J Natl Cancer Inst; 1988 Jul; 80(9):698. PubMed ID: 2897474
    [No Abstract]   [Full Text] [Related]  

  • 26. Adenosine deaminase, acquired immunodeficiency syndrome (AIDS), and hepatitis B infection.
    Martínez-Hernández D; Arenas Barbero J; Jaqueti Aroca J; Pérez-Piqueras FJ; Santos Sancho J; Cosín Ochaitia J; Gómez de Terreros FJ
    Clin Chem; 1992 Jan; 38(1):162-3. PubMed ID: 1733592
    [No Abstract]   [Full Text] [Related]  

  • 27. S-Adenosylhomocysteine accumulation and selective cytotoxicity in cultured T- and B-lymphocytes.
    Palella TD; Schatz RA; Wilens TE; Fox IH
    J Lab Clin Med; 1982 Aug; 100(2):269-78. PubMed ID: 6980250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of 2'-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice.
    Helland S; Ueland PM
    Cancer Res; 1983 Sep; 43(9):4142-7. PubMed ID: 6603264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. S-adenosylhomocysteine hydrolase activity in defects of enzymes of purine metabolism and inhibition by various purine compounds.
    Chaléon J; Pérignon JL; Hamet M; Cartier PH
    Adv Exp Med Biol; 1984; 165 Pt B():71-4. PubMed ID: 6720453
    [No Abstract]   [Full Text] [Related]  

  • 30. Expression, purification, and characterization of recombinant S-adenosylhomocysteine hydrolase from the thermophilic archaeon Sulfolobus solfataricus.
    Porcelli M; Fusco S; Inizio T; Zappia V; Cacciapuoti G
    Protein Expr Purif; 2000 Feb; 18(1):27-35. PubMed ID: 10648166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. S-adenosylhomocysteine hydrolase activity in horses, Equus cabalus, with severe combined immunodeficiency.
    Magnuson NS; Decker DM; Perryman LE
    Comp Biochem Physiol B; 1983; 75(1):113-7. PubMed ID: 6602030
    [No Abstract]   [Full Text] [Related]  

  • 32. Inactivation of liver S-adenosylhomocysteine hydrolase in vitro of rats treated with erythro-9-(2-hydroxynon-3-yl)adenine.
    Kajander EO
    Biochem J; 1982 Sep; 205(3):585-92. PubMed ID: 6983348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-adenosylhomocysteine hydrolase inactivation and purine toxicity in cultured human T- and B-lymphoblasts.
    Young GJ; Hallam LJ; Jack I; Van Der Weyden MB
    J Lab Clin Med; 1984 Jul; 104(1):86-95. PubMed ID: 6330251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetic properties of human erythrocyte adenosylhomocysteinase.
    Salerno C; Bozzi A; Crifò C; Strom R
    Adv Exp Med Biol; 1986; 195 Pt A():271-4. PubMed ID: 3728156
    [No Abstract]   [Full Text] [Related]  

  • 35. Carrier erythrocyte entrapped adenosine deaminase therapy in adenosine deaminase deficiency.
    Bax BE; Bain MD; Fairbanks LD; Simmonds HA; Webster AD; Chalmers RA
    Adv Exp Med Biol; 2000; 486():47-50. PubMed ID: 11783525
    [No Abstract]   [Full Text] [Related]  

  • 36. S-Adenosylhomocysteine metabolism in adenosine deaminase deficient cells.
    Hershfield MS; Kredich NM
    Adv Exp Med Biol; 1980; 122A():421-5. PubMed ID: 7424659
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum adenosine deaminase activity in HIV positive subjects. A hypothesis on the significance of ADA2.
    Gakis C; Calia G; Naitana A; Pirino D; Serru G
    Panminerva Med; 1989; 31(3):107-13. PubMed ID: 2689968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selection and characterization of a murine lymphoid cell line partially deficient in S-adenosylhomocysteine hydrolase.
    Kamatani N; Willis EH; Carson DA
    Biochim Biophys Acta; 1983 Apr; 762(2):205-14. PubMed ID: 6600937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory treatment.
    Folkers K; Langsjoen P; Nara Y; Muratsu K; Komorowski J; Richardson PC; Smith TH
    Biochem Biophys Res Commun; 1988 Jun; 153(2):888-96. PubMed ID: 3382410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reactivation of S-adenosylhomocysteine hydrolase activity in cells exposed to 9-beta-D-arabinofuranosyladenine.
    Helland S; Ueland PM
    Cancer Res; 1982 Jul; 42(7):2861-6. PubMed ID: 6979384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.